The Value of Infrared Thermography to Assess Foot and Limb Perfusion in Relation to Medical, Surgical, Exercise or Pharmacological Interventions in Peripheral Artery Disease: A Systematic Review.
Giovanni PivaAnna CrepaldiGladiol ZenunajLorenzo CarusoNatascia RinaldoVincenzo GasbarroNicola LambertiPablo Jesús Lopez SotoFabio ManfrediniPublished in: Diagnostics (Basel, Switzerland) (2022)
Infrared thermography (IRT) is a promising imaging method in patients with peripheral artery disease (PAD). This systematic review aims to provide an up-to-date overview of the employment of IRT as both a diagnostic method and an outcome measure in PAD patients in relation to any kind of intervention. On September 2022, MEDLINE, EMBASE, CENTRAL, Google Scholar, Web of Science, and gray literature were screened. Eligible articles employing IRT in PAD were screened for possible inclusion. The RoB 2.0 tool was used to assess the risk of bias. Twenty-one eligible articles were finally included, recruiting a total of 1078 patients. The IRT was used for PAD diagnosis/monitoring in 11 studies or to assess the effect of interventions (revascularization, pharmacological therapy, or exercise rehabilitation) in 10 studies. The analysis of the included papers raised high concerns about the overall quality of the studies. In conclusion, IRT as a noninvasive technique showed promising results in detecting foot perfusion in PAD patients. However, limits related to devices, points of reference, and measurement conditions need to be overcome by properly designed trials before recommending its implementation in current vascular practice.
Keyphrases
- end stage renal disease
- systematic review
- ejection fraction
- healthcare
- newly diagnosed
- chronic kidney disease
- physical activity
- peritoneal dialysis
- prognostic factors
- randomized controlled trial
- primary care
- stem cells
- public health
- computed tomography
- magnetic resonance imaging
- high intensity
- mental health
- coronary artery disease
- body composition
- contrast enhanced
- patient reported
- case control
- bone marrow
- coronary artery bypass grafting
- drug induced